Oxycodone Hydrochloride Oral Solution

Oxycodone is a potent semi-synthetic opioid agonist prescribed for the management of severe pain. It works by altering the brain's perception of pain through specific receptors in the central nervous system.

Dosage for oxycodone must be highly individualized based on the patient's pain severity, prior opioid exposure, and individual response. Healthcare providers follow the principle of "start low and go slow" to minimize side effects.

• Opioid-Naive Patients (Immediate Release): For patients not currently taking opioids, the typical starting dose is 5 mg to 15 mg every 4 to 6 hours as needed for pain.
• Opioid-Tolerant Patients: Patients who have been taking other opioids may require higher starting doses. The provider will use an equianalgesic conversion table to calculate a safe starting point.
• Extended-Release (ER) Dosing: ER tablets are usually started at 10 mg every 12 hours. These are NOT for "as needed" (PRN) use. They are intended for patients who require continuous, around-the-clock pain control.
• Maximum Dose: There is no formal ceiling dose for pure oxycodone; however, the dose is limited by side effects, particularly respiratory depression. If using combination products (e.g., with acetaminophen), the dose is strictly limited by the maximum daily allowance of the non-opioid component (usually 4,000 mg of acetaminophen).

Oxycodone use in children is generally restricted. The immediate-release formulations are sometimes used off-label in pediatric populations for severe post-operative pain under strict hospital supervision, often calculated by weight (e.g., 0.05 mg/kg to 0.15 mg/kg). The extended-release formulation (OxyContin) is FDA-approved only for opioid-tolerant children aged 11 years and older who have a condition requiring daily, long-term opioid treatment. Use in children younger than 11 for chronic pain is not recommended and has not been established as safe.

Renal Impairment

Because oxycodone is excreted by the kidneys, patients with reduced renal function (CrCl < 60 mL/min) may experience drug accumulation. Healthcare providers typically start these patients at 50% to 75% of the standard dose and monitor closely for signs of sedation or respiratory depression.

Hepatic Impairment

Since the liver metabolizes oxycodone, patients with hepatic insufficiency (liver failure) will have higher plasma concentrations. For patients with mild to moderate liver impairment, the starting dose should be reduced, and the interval between doses may be lengthened.

Elderly Patients

Older adults are more sensitive to the effects of opioids. Providers often start with the lowest possible dose (e.g., 2.5 mg to 5 mg) due to the increased risk of confusion, falls, and slowed breathing in this population.

1. 1Consistency: Immediate-release forms can be taken with or without food. If the medication causes nausea, taking it with a meal may help.
2. 2Swallow Whole: Extended-release tablets (ER) must be swallowed whole. Never crush, chew, break, or dissolve them. Doing so releases the entire 12-hour dose at once, which can be fatal.
3. 3Liquid Measurement: If using the oral solution, always use a calibrated medication measuring device (oral syringe or dose cup). A household teaspoon is not accurate.
4. 4Storage: Store oxycodone at room temperature in a secure, locked location. This is critical to prevent accidental ingestion by children or theft/misuse by others.
5. 5Disposal: Unused oxycodone should be taken to a drug take-back site or, if unavailable, flushed down the toilet (as per FDA "flush list" guidelines for high-risk medications).

If you miss a dose of immediate-release oxycodone, take it as soon as you remember, unless it is almost time for your next dose. For extended-release forms, if you miss a dose, skip it and return to your regular schedule. Never double the dose to make up for a missed one, as this significantly increases the risk of overdose.

An oxycodone overdose is a medical emergency. Signs include pinpoint pupils, extreme drowsiness, cold/clammy skin, limp muscles, and dangerously slow or stopped breathing. If an overdose is suspected, call 911 immediately. If available, administer Naloxone (Narcan) according to the package instructions. Naloxone is an opioid antagonist that can temporarily reverse the effects of the overdose while waiting for emergency responders.

> Important: Follow your healthcare provider's dosing instructions. Do not adjust your dose without medical guidance.

Most patients taking oxycodone will experience at least one side effect. These are generally manageable but should be monitored:

• Constipation: This is the most common side effect and, unlike others, does not go away with time. Opioids slow down the movement of the digestive tract. Patients are often advised to start a bowel regimen (stimulant laxative and stool softener) proactively.
• Nausea and Vomiting: This often occurs during the first few days of treatment as the body adjusts. It may be worse when standing up (orthostatic hypotension).
• Somnolence (Drowsiness): Many patients feel sleepy or "foggy." This typically improves after a few days of consistent dosing.
• Dizziness: A feeling of lightheadedness, especially when moving from a sitting to a standing position.

Oxycodone is a high-alert medication. It must only be used by the person for whom it was prescribed. Sharing this medication with others is illegal and dangerous. Patients should be screened for a personal or family history of substance abuse before starting treatment. It is also essential to inform your doctor if you have a history of depression or other mental health conditions, as opioids can exacerbate these issues.

As detailed in the side effects section, the FDA mandates a Black Box Warning for oxycodone regarding its potential for addiction, fatal respiratory depression, and dangerous interactions with benzodiazepines and alcohol. These warnings emphasize that oxycodone should only be used when other non-opioid treatments are insufficient. The warning also highlights the risk of Neonatal Opioid Withdrawal Syndrome (NOWS) if used during pregnancy.

• Allergic Reactions: While rare, anaphylaxis can occur. If you have a known allergy to codeine or other opioids, you may be cross-sensitive to oxycodone.

• MAO Inhibitors (MAOIs): Do not use oxycodone if you have taken an MAOI (such as linezolid, phenelzine, or selegiline) in the last 14 days. This combination can lead to unpredictable and severe reactions, including respiratory depression or extreme changes in blood pressure.
• Alcohol: As noted, the combination is potentially fatal due to additive CNS depression.

• Benzodiazepines and CNS Depressants: Drugs like alprazolam (Xanax), diazepam (Valium), or sleep medications (Zolpidem) increase the risk of profound sedation and respiratory failure.
• CYP3A4 Inhibitors: Medications like ketoconazole, erythromycin, and ritonavir can slow the metabolism of oxycodone, leading to toxic levels in the blood.

Oxycodone must NEVER be used in the following circumstances:

• Significant Respiratory Depression: If a patient has pre-existing respiratory failure or significantly slowed breathing, oxycodone can be fatal.
• Acute or Severe Bronchial Asthma: In an unmonitored setting or in the absence of resuscitative equipment, opioids can cause fatal airway constriction and respiratory arrest.
• Gastrointestinal Obstruction: This includes known or suspected paralytic ileus. Opioids slow gastric motility, which can lead to bowel perforation or toxic megacolon in these patients.
• Hypersensitivity: Any known severe allergy to oxycodone hydrochloride or any of the inactive ingredients in the formulation.

Oxycodone is traditionally classified as FDA Pregnancy Category C (under the old system). There are no adequate and well-controlled studies in pregnant women. However, prolonged use of oxycodone during pregnancy can result in Neonatal Opioid Withdrawal Syndrome (NOWS). This is a life-threatening condition for the newborn, characterized by irritability, hyperactivity, abnormal sleep patterns, high-pitched cry, tremors, vomiting, diarrhea, and failure to gain weight. Use during labor can also cause respiratory depression in the newborn. Oxycodone should only be used during pregnancy if the potential benefit justifies the potential risk to the fetus.

Oxycodone is excreted in human milk. Low levels of oxycodone have been detected in the plasma of breastfed infants. There is a risk of sedation and respiratory depression in the nursing infant. If a breastfeeding mother must take oxycodone, the infant should be closely monitored for excessive sleepiness, difficulty breastfeeding, or limpness. Withdrawal symptoms can also occur in the infant when the mother stops taking the medication or stops breastfeeding.

Oxycodone is a semi-synthetic pure opioid agonist. Its primary therapeutic action is analgesia. It interacts predominantly with the mu-opioid receptors, which are coupled with G-protein receptors. By activating these receptors, oxycodone inhibits the release of neurotransmitters such as substance P, glutamate, and acetylcholine. This inhibition occurs at both the pre-synaptic and post-synaptic levels in the spinal cord and brain, effectively blocking the transmission of pain impulses to the cerebral cortex.

Oxycodone exerts its effects mainly on the central nervous system (CNS) and the smooth muscles. In addition to analgesia, it causes respiratory depression by direct action on brainstem respiratory centers. It also suppresses the cough reflex and causes miosis (pupillary constriction). In the digestive system, it decreases the motility of the stomach and intestines, leading to increased smooth muscle tone and constipation.

| Parameter | Value |

|---|---|